Skip Navigation
You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
U.S. Department of Health and Human Services
•
National Institutes of Health
Advanced Search
NIAID Home
Health & Research A to Z
Labs & Scientific Resources
Funding
About NIAID
News & Events
NIAID
>
About NIAID
>
Organization
>
Division of Allergy, Immunology, and Transplantation
>
NIAID Strategic Plan for Research on Vaccine Adjuvants
NIAID Strategic Plan for Research on Vaccine Adjuvants
Introduction
Plan
Appendices
Skip Website Tools
Website Tools
Email this page
Print this page
Order publications
Skip Stay Connected
Stay Connected
News Releases
Media Availability: Peanut Therapy Shows Promise in Treating Peanut Allergy
Oral Immunotherapy Shows Promise as Treatment for Egg Allergy
July 18, 2012
Rate of Severe Reactions Higher Than Thought in Young Children with Food Allergies
June 25, 2012
Statement: World Asthma Day
April 30, 2012
NIAID Announces New Director for the Division of Extramural Activities
April 23, 2012
Highlights
HHS Initiatives and Projects on Organ Donation
Decision: Donation A School Program That Gives the Gift of Life
Food Allergy Clinical Guidelines
Javascript Error
Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.
Division of Allergy, Immunology, and Transplantation (DAIT)
Skip Content Marketing
Share this:
NIAID Strategic Plan for Research on Vaccine Adjuvants - Table of Contents
Introduction
Scientific Background on Adjuvants
Governmental Sponsorship of Research on Adjuvant Discovery and Development
Evolution of NIAID Adjuvant Research Programs
NIAID Strategic Plan for Research on Vaccine Adjuvants
Basic Immunology and Early Stage Adjuvant Discovery
Immediate Goals
Long-Term Goals
Later Stage Adjuvant Development and Preclinical Testing
Immediate Goals
Long-Term Goals
Clinical Assessment of Adjuvants
Immediate Goals
Long-Term Goals
Appendices
Appendix 1: Planning Process
Appendix 2: Examples of Adjuvant Types Approved for Human Use in Preventive Vaccines or Tested in Human Studies
Appendix 3: Status of NIAID Adjuvant Research Activities
Introduction
NIAID Extramural Research Activities
DAIT
DMID
DAIDS
NIAID Intramural Research Activities
DIR
VRC
Last Updated October 24, 2011
Last Reviewed June 24, 2011